Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Trastuzumab Emtansine In Comb W/ Atezolizumab/Atezolizumab-Placebo In Pts W/ Her2-+ Adv/ Meta

Protocol: OSU-16193

Full Title

A Randomized, Multicenter, Double-Blind,Placebo- Controlled Phase II Study Of The Efficacy And Safety Of Trastuzumab Emtansine In Combination With Atezolizumab Or Atezolizumab-Placebo In Patients With Her2-Positive Locally Advanced Or Metastatic Breast Cancer Who Have Received Prior Trastuzumab And Taxane Based Therapy.

Breast Cancer